Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 939,254.0 | $349.1M | 12.03% | -214K | -18.5% | $371.67 | -3.2% |
| 2 | CELC | CELCUITY INC | Healthcare | 1,704,318.0 | $178.3M | 6.14% | +420K | +32.7% | $104.62 | -9.1% |
| 3 | TGTX | TG THERAPEUTICS INC | Healthcare | 2,927,895.0 | $160.9M | 5.54% | -1.1M | -27.3% | $54.94 | +0.2% |
| 4 | PODD | INSULET CORP | Healthcare | 1,049,000.0 | $159.7M | 5.50% | +486K | +86.5% | $152.25 | -5.8% |
| 5 | NVCR | NOVOCURE LTD | Healthcare | 9,913,401.0 | $150.2M | 5.17% | -579K | -5.5% | $15.15 | +18.1% |
| 6 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 225,587.0 | $122.2M | 4.21% | +38K | +20.5% | $541.83 | -4.6% |
| 7 | INSP | INSPIRE MED SYS INC | Healthcare | 1,931,436.0 | $86.2M | 2.97% | +1.4M | +235.1% | $44.61 | +38.5% |
| 8 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 1,843,504.0 | $72.1M | 2.48% | +1.8M | +10000.0% | $39.12 | +18.8% |
| 9 | ANIP | ANI PHARMACEUTICALS INC | Healthcare | 867,760.0 | $71.8M | 2.48% | +48K | +5.8% | $82.78 | -9.9% |
| 10 | BBNX | BETA BIONICS INC | Healthcare | 4,393,714.0 | $68.8M | 2.37% | +39K | +0.9% | $15.67 | +23.4% |
| 11 | VCEL | VERICEL CORP | Healthcare | 1,459,152.0 | $64.9M | 2.24% | -1.1M | -42.8% | $44.49 | -4.6% |
| 12 | — | PRAXIS PRECISION MEDICINES I | — | 177,517.0 | $59.4M | 2.05% | -153K | -46.3% | $334.79 | — |
| 13 | GERN | GERON CORP | Healthcare | 42,808,659.0 | $54.8M | 1.89% | +1.3M | +3.1% | $1.28 | +19.5% |
| 14 | ALKS | ALKERMES PLC | Healthcare | 1,029,252.0 | $53.9M | 1.86% | -942K | -47.8% | $52.40 | -6.2% |
| 15 | ERAS | ERASCA INC | Healthcare | 2,700,000.0 | $49.5M | 1.70% | NEW | — | $18.32 | +4.5% |
| 16 | NPCE | NEUROPACE INC | Healthcare | 2,911,122.0 | $46.3M | 1.59% | -21K | -0.7% | $15.89 | -7.6% |
| 17 | PGNY | PROGYNY INC | Healthcare | 1,602,000.0 | $46.2M | 1.59% | -465K | -22.5% | $28.83 | -8.5% |
| 18 | INDV | INDIVIOR PHARMACEUTICALS INC | Healthcare | 1,064,000.0 | $43.7M | 1.50% | -210K | -16.5% | $41.03 | -12.7% |
| 19 | — | PARABILIS MEDICINES INC | — | 1,465,070.0 | $40.1M | 1.38% | NEW | — | $27.37 | — |
| 20 | EDAP | EDAP TMS S A | Healthcare | 7,309,254.0 | $37.9M | 1.30% | — | — | $5.18 | -0.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%